Pravin Dugel Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 19 hours ago
Pravin Dugel has an estimated net worth of at least $28.5 million*, as of Sept. 16, 2026. They own 2.5 million shares of OCUL stock. They have sold 315,117 shares of OCUL stock since 2021, for an estimated $2.8 million.
Pravin Dugel $OCUL SEC Form 4 Insider Trading
Pravin Dugel has filed a total of 10 insider trades in $OCUL since 2021. Their most recent trade was a sale of 21,649 shares, made on Aug 24, 2026. Their largest trade was a sale of 124,882 shares, made on Feb 12, 2026. We estimate that they now own 2.5 million shares of $OCUL, worth an estimated $25.8 million.
Insider Trading at $OCUL
There have been a total of 93 insider trades reported at $OCUL since 2021, with 3.1 million shares purchased and 657,402 shares sold. The most active insider traders in $OCUL stock have been Pravin Dugel, Sanjay Nayak, and Jeffrey S. Heier. The most recent trade was a sale of 3,035 shares reported by Peter Kaiser (Chief Development Officer), made on Aug 24, 2026.
History of Insider Stock Trades by Pravin Dugel
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
OCUL
|
Sale | 21,649 | Aug 24, 2026 | Aug. 26, 2026, 7:11 p.m. |
|
OCUL
|
Sale | 21,156 | May 26, 2026 | May 28, 2026, 4:08 p.m. |
|
OCUL
|
Sale | 20,056 | Feb 23, 2026 | Feb. 25, 2026, 7:20 p.m. |
|
OCUL
|
Sale | 124,882 | Feb 12, 2026 | Feb. 17, 2026, 9:29 p.m. |
|
OCUL
|
Sale | 21,494 | Aug 25, 2025 | Aug. 27, 2025, 6:41 p.m. |
|
OCUL
|
Sale | 21,219 | May 23, 2025 | May 27, 2025, 5:37 p.m. |
|
OCUL
|
Sale | 21,475 | Feb 24, 2025 | Feb. 26, 2025, 7:27 p.m. |
|
OCUL
|
Sale | 20,680 | Nov 25, 2024 | Nov. 27, 2024, 8:47 a.m. |
|
OCUL
|
Sale | 20,880 | Aug 23, 2024 | Aug. 27, 2024, 5:17 p.m. |
|
OCUL
|
Sale | 21,626 | May 23, 2024 | May 28, 2024, 5 p.m. |
$OCUL Executives and Stock Owners with Insider Trades
-
Pravin Dugel, See Remarks
-
Sanjay Nayak, Chief Strategy Officer
-
Jeffrey S. Heier, Chief Scientific Officer
-
Peter Kaiser, Chief Development Officer
-
Antony C. Mattessich, President and CEO
-
Nadia Waheed, Chief Medical Officer
-
Rabia Gurses Ozden, Chief Medical Officer
-
Christopher G White, Chief Business Officer
-
Donald Notman, Chief Financial Officer
-
Donald Notman, Chief Operating Officer
-
Donald Notman, See Remarks
-
Philip C. Strassburger, General Counsel
-
Namrata Saroj, Chief Business Officer
-
Todd Anderman, Chief Legal Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.